Status:
UNKNOWN
National Observatory of Children Hospitalized for Bronchiolitis
Lead Sponsor:
Association Clinique Thérapeutique Infantile du val de Marne
Collaborating Sponsors:
Sanofi
Conditions:
Bronchiolitis
Eligibility:
All Genders
1-12 years
Brief Summary
This study is an observational, multicenter and prospective study for surveillance of case of hospitalised children for bronchiolitis associated or not to RSV or other viruses (isolated or associated ...
Detailed Description
The aim of this surveillance is to observe and describe the cases hospitalized for bronchiolitis in the 2023/2024 season in the context of routine immunization with Nirsevimab.
Eligibility Criteria
Inclusion
- Children under 12 months of age
- In one of the 6 study sites
- From October 15, 2023
- For acute bronchiolitis defined according to current national and international recommendations
- Hospitalized from the pediatric emergency department.
Exclusion
- \- Refusal to participate by patient relative or legal representative
Key Trial Info
Start Date :
October 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT06112132
Start Date
October 15 2023
End Date
September 30 2024
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ACTIV
Créteil, France, 94000